Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate |
1998-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5311adcc1cfbf472a4e2f98fa98a1d5 |
publicationDate |
2000-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1000623-A1 |
titleOfInvention |
Use of epinastine as antitussivum |
abstract |
The present invention relates to a new use of use of epinastine in the form of itsnenantiomers, a mixture of enantiomers or as a racemate epinastine for thenpreparation of a medicament with antitussive activity or for the preparation of anmedicament with an enhancement of the antitussive effects of antitussiva known fromnthe state of the art - in particular of centrally acting antitussiva of the codeine orndihydrocodeine type. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0220018-A1 |
priorityDate |
1998-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |